CTOR
Citius Oncology, Inc.
Sector: Pharmaceutical PreparationsIndustry: Medical - PharmaceuticalsCountry: USExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 26 of CITIUS ONCOLOGY, INC.'s SEC filings and found 17 warrant series, 2 convertibles, 3 shelf registrations, 1 S-1 registration and 4 completed offerings on file for CTOR. The latest dilution event on file is a registration statement on Jun 5, 2026. Analysis updated Sep 25, 2026.